Photo taken from Elisa Agostinetto/X
Nov 25, 2023, 17:03
Elisa Agostinetto: Recent findings from MonarchE and NataLEE trials
Elisa Agostinetto, Medical Research Fellow at Brussels University Hospital, recently posted X/Twitter:
“Adjuvant CDK4/6i for early breast cancer: how to choose wisely⁉️
In this work, we discuss the most recent findings from MonarchE and NataLEE trials and put them in perspective for potential use in clinical practice.”
For the article click here.
Source: Elisa Agostinetto/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 21:47
Nov 21, 2024, 21:40
Nov 21, 2024, 21:36
Nov 21, 2024, 21:27
Nov 21, 2024, 21:23
Nov 21, 2024, 21:17
Nov 21, 2024, 21:07
Nov 21, 2024, 17:57